Veracyte Inc (NASDAQ:VCYT)
| 21.09 Delayed Data As of 4:00pm ET |  +1.20 / +6.03%Today’s Change | 14.85 Today|||52-Week Range 54.13 | -48.81% Year-to-Date |
Latest VCYT News | Press Releases
No recent news for Veracyte Inc.
Today’s Trading
| Previous close | 19.89 |
| Today’s open | 20.04 |
| Day’s range | 20.02 - 21.25 |
| Volume | 73,597 |
| Average volume (3 months) | 1,005,696 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -69.74% |
| Earnings growth (this year) | +20.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +86.85% |
| P/E ratio | NM |
| Price/Sales | 12.74 |
| Price/Book | 1.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYGNMyriad Genetics Inc | +0.51 | +2.82% |
| VIVOMeridian Bioscience ... | +0.46 | +1.51% |
| CLDXCelldex Therapeutics... | -4.46 | -16.54% |
| CDNACareDx Inc | +0.91 | +4.23% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $219.5M |
| Annual profit (last year) | -$75.6M |
| Net profit margin | -34.42% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
